|

Pfizer Inc. and the Massachusetts Institute of Technology (MIT) have held the official groundbreaking of the new location of Pfizer’s Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at Cambridge, MA.
Pfizer plans to bring around 400 new research jobs to Cambridge. In addition to relocating key Pfizer scientists to the area, the company anticipates hiring a significant number of scientists for the two research units, including biologists, chemists and individuals with other areas of research expertise.
Read the full story >>
|